ALISHA CARTER: Open Payments
NPI 1518396084 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 62 payments from 9 companies in 2025. Trend: 2023 $624 · 2024 $547 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $318 |
| ABBVIE INC. | 10 | $245 |
| Teva Pharmaceuticals USA, Inc. | 11 | $238 |
| Lundbeck LLC | 10 | $171 |
| Neurocrine BioSciences, Inc. | 9 | $168 |
| Otsuka America Pharmaceutical, Inc. | 9 | $148 |
| Alkermes, Inc. | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, ABILIFY MAINTENA, INGREZZA, ABILIFY ASIMTUFII, REXULTI, ARISTADA.
Industry payments across NC — which companies pay providers there.
